Paul is a lawyer at Brinkhof who specialises in national and international patent cases, with a particular focus on patent litigation concerning pharmaceutical and medical devices. He has extensive experience in assisting both right-holders and alleged infringers, and international coordination plays a crucial role in his work. The area of law Paul has registered with the Dutch bar is intellectual property.
Experience & ancillary activities
In 2014, Paul graduated cum laude with a Master’s in Law and Technology from Tilburg University. He also gained research experience by taking a Research Master’s in Law, jointly offered by Tilburg University and Katholieke Universiteit Leuven, and as a result of his work for the Tilburg Institute for Law, Technology and Society (TILT), including on the Robolaw project.
Paul is an avid contributor to publications in the field of patent law. He is also a co-author of publications by the European Patent Office, including Patent Enforcement in Europe and Compulsory Licensing in Europe. He also shares his expertise as a lecturer in continuing professional development courses for patent attorneys and at the University of Groningen. In addition to his academic pursuits, Paul is a member of AIPPI (International Association for the Protection of Intellectual Property) and Young EPLAW (European Patent Lawyers Association). He was admitted to the Dutch bar in 2015.
Some of the cases Paul Marcelis has handled:
- representing Unilever in an international dispute concerning antibodies;
- representing Accord in several pharmaceutical disputes, including with regard to methotrexate;
- representing Novozymes in an international dispute concerning enzyme preparations;
- representing Gedeon Richter in an international dispute concerning its adalimumab patent;
- representing Becton Dickinson in a global medical device dispute.